載入...
Molecular pathology of lung cancer: clinical aspects
Discovery of tyrosine kinase inhibitor sensitizing mutations in lung cancer (LC) appears to be the main event in clinical oncology of the last decade. Activating lesions in epidermal growth factor receptor (EGFR) gene almost guarantee tumor response to gefitinib, erlotinib or afatinib.ALK translocat...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Russo |
| 出版: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2016-02-01
|
| 叢編: | Sibirskij Onkologičeskij Žurnal |
| 主題: | |
| 在線閱讀: | https://www.siboncoj.ru/jour/article/view/255 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|